Naproxen Sodium
NDC 43063-909, Naproxen Sodium, tablet, film coated, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 43063-909
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA074661
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43063-909 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43063-909-20 | 43063090920 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-909-20) |
| 43063-909-30 | 43063090930 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-909-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43063-909 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43063-909 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43063-909. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.